Abstract:A 34-year-old Chinese woman was referred to our hospital at 24 weeks of gestation for persistent hypokalaemia and new onset of hypertension. Prior to pregnancy, she had a three-year history of recurrent episodes of muscle weakness and found to have low potassium levels (the lowest level was 1.8 mmol/L, normal 3.5–5.3 mmol/L). During the clinical visits, her blood pressure was normal, consistently 110–120/70–80 mmHg, until the twenty-third week of pregnancy, when it was found to be 160/100 mmHg. During her hospitalisation, blood pressure remained elevated despite treatment, with a peak level of 210/130 mmHg. Diagnostic evaluation included potassium levels, which remained low at 2.94–3.65 mmol/L despite supplementation; urinary protein was 1.98 g/24 h; urinary potassium excretion was 48 mmol/24 h, suggesting renal loss of potassium. The plasma renin activity (PRA) was 0.76 ng/mL/h (normal 0.2–1.9 ng/mL/h in non-pregnancy); plasma aldosterone concentration (PAC) was 830 pg/mL (normal 21–136 pg/mL in non-pregnancy), with a PAC-to-PRA ratio of 109. Urine catecholamines, plasma corticotrophin, cortisol and calcium concentrations were almost normal. Ultrasound scan identified a parenchymatous mass in the left adrenal gland. Primary aldosteronism was suspected, but surgery during pregnancy was not considered due to lack of expertise in this setting, though laparoscopic adrenalectomy during pregnancy might be a possible choice for treatment. Conservative treatment was adopted to prolong the pregnancy as much as possible, including nitroglycerin, nifedipine, labetabol, furosemide, magnesium sulfate, potassium supplement and other supportive therapies. Spironolactone was not adopted considering its uncertain effect to the fetus, although there was a report of it being used safely at high dose in a mother with Batter’s syndrome for two pregnancies without evidence of harm to male infants. Emergency caesarean section was performed at the twenty-fifth week of gestation because of HELLP syndrome (type III), uncontrolled hypertension and mild placental abruption. Her blood pressure decreased after delivery but not to normal. Abdominal computed tomography six months later confirmed a tumour in the left adrenal gland (Fig. 1). Laparoscopic adrenalectomy was then performed and pathological analysis confirmed a cortical adenoma of the left adrenal gland. After surgery, her serum potassium level and blood pressure gradually returned to normal. PRA, PAC and PAC-to-PRA ratio all returned to normal after three months. On follow up, serum potassium levels and blood pressure have remained normal without medication. This patient was not hypertensive in early pregnancy, most probably due to the physiological vasodilation that occurs in pregnancy. Hypertension due to Conn’s may not become apparent until midto late pregnancy (as occurred for this patient) or until post-partum. Persistent hypokalaemia, with increased potassium loss in urine, as occurred in this case, Correspondence: Professor Hong Li, 3 East Qingchun Road, Sir Run Run Shaw Hospital, Hangzhou 310016, China. Email: lihongheyi@126.com

A Case of Severe Polyhydramnios During Pregnancy Associated with Long-Term Use of Lithium

A case of pregnancy with severe polyhydramnios related to long‐term use of lithium

Obstetric Outcomes in Women on Lithium: A Systematic Review and Meta-Analysis

The Dilemma of Lithium Discontinuation in Bipolar Disorder During Pregnancy Planning: A Case Report and Literature Review

Lithium nephropathy in Bipolar Disorder: a clinical challenge

Dose response relationship between lithium serum levels during pregnancy and birth outcomes

Epidemiology studies on effects of lithium salts in pregnancy are confounded by the inability to control for other potentially teratogenic factors

Retrospective Review of Postpartum Lithium Use Including During Lactation

Study on the Safety of Antiepileptic Drugs during Pregnancy

Lithium Use During Pregnancy and the Risk of Miscarriage.

Lithium Induced Amenorrhea: A First Case Report

Case Series: The use of Lithium in Bipolar Affective Disorder and End-Stage Renal Disease

Lithium in Breast Milk Transiently Affects the Renal Electrolytic Balance of Infants

Navigating the Complexity of a Bipolar Pregnant Patient With Multiple Comorbidities

Primary Aldosteronism and Pregnancy: A Case Report

Lithium Use During Pregnancy in 14 Countries

Severe hyponatremia in obstetrics: Presentations and outcome. Retrospective cohort over 10 years

Striking the Balance: Bipolar Disorder in the Perinatal Period

Use of Long-Acting Injectables for Severe Mental Illness in the Peripartum Period: A Case Report and a Scoping Review

Our old friend lithium and encephalopathy: a case report

MO502: Use of Lithium, Valproate and the Risk of Acute or Chronic Kidney Disease: An Observational Study From Routine Care Data